19/11/2024  07:57:05 Var. +1.3500 Volume Denaro14:26:38 Lettera14:26:38 Capitalizzazione di mercato Dividend Y. Rapporto P/E
229.4500EUR +0.59% -
Fatturato: -
224.8500Quantità in denaro: 30 229.3500Quantità in lettera: 30 45.18 bill.EUR - -

Descrizione business

Cencora, formerly known as AmerisourceBergen, is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, Cencora delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Steven H. Collis
Consiglio di amministrazione
James F. Cleary, Jr., Elizabeth S. Campbell, Gina K. Clark, Kourosh Q. Pirouz, Lazarus Krikorian, Leslie E. Donato, Robert P. Mauch, Silvana Battaglia, Jennifer Dubas
Consiglio di sorveglianza
Steven H. Collis, D. Mark Durcan, Dennis M. Nally, Henry W. McGee, Kathleen W. Hyle, Lon R. Greenberg, Ornella Barra, Richard W. Gochnauer, Redonda Miller, Lorence H. Kim, M.D.
 

Dati aziendali

Name: Cencora Inc
Indirizzo: 1 West First Avenue,Conshohocken, PA 19428-1800, USA
Telefono: +1-610-727-7000
Fax: +1-800-640-5221
E-mail: InvestorRelations@cencora.com
Internet: https://www.cencora.com/
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 30/09
Flottante libero: 55.10%
Data dell'IPO: 04/04/1995

Rapporti con gli investitori

Name: Bennett Murphy
IR telefono: +1-610-727-3693
IR Fax: -
IR e-mail: bennett.murphy@cencora.com

Company calendar

CW 48 | 29/11/2024 Dividend Payment
 

Principali azionisti

Altri
 
58.24%
Vanguard Group
 
10.28%
BlackRock Inc.
 
9.86%
PRICE T ROWE ASSOCIATES INC MD
 
5.36%
State Street Corporation
 
3.95%
JP Morgan Chase & Co.
 
2.73%
FMR LLC.
 
2.31%
Boston Partners
 
2.02%
Wellington Management Group
 
1.90%
Altri
 
3.35%